(NPR) U.S. Recommends Pausing Use Of Johnson & Johnson Vaccine Over Blood Clot Concerns

U.S. Recommends Pausing Use Of Johnson & Johnson Vaccine Over Blood Clot Concerns

class="imagewrap has-source-dimensions"
data-crop-type="wide"
style="
--source-width: 6000;
--source-height: 3374;
"
>

The U.S. Food and Drug Administration and the Centers for Disease Control and Prevention have recommended a pause in the use of the Johnson & Johnson COVID-19 vaccine, shown here in a hospital in Denver.



David Zalubowski/AP


hide caption

toggle caption

David Zalubowski/AP

Coronavirus Updates

U.S. Recommends Pausing Use Of Johnson & Johnson Vaccine Over Blood Clot Concerns

In a statement on Tuesday, U.S. authorities said they are "reviewing data involving six reported U.S. cases of a rare and severe type of blood clot in individuals after receiving the J&J vaccine."